top of page

Search Results

Search results for "Helen Su"

Results found for "Helen Su"

  • Scaling GLP 1 Receptor Tools Through Academia Industry Collaboration | Dr. GPCR Ecosystem

    research focuses on bottom-up chemical tool development for imaging and interrogating GPCRs and other cell-surface Originally trained as a veterinary surgeon, he conducted postdoctoral research at the CNRS in Montpellier

  • Jacob Lee and Jin Cho: Rebuilding the Software Layer Under Modern Research | Dr. GPCR Ecosystem

    Episode Timeline Timestamps were generated using AI for readability. 00:00 Summit week welcome and episode And what surprised me even more was his lab was paying thousands of dollars for this legacy-looking software

  • Charlotte Crauwels: Designing Hybrid GPCRs with Computational Protein Engineering | Dr. GPCR Ecosystem

    In this conversation, Charlotte Crauwels discusses her work developing computational strategies to support Her work integrates bioinformatics, protein modeling, and experimental collaboration to support GPCR Successful GPCR research increasingly depends on close collaboration between these two domains. “Every time you think you understand GPCRs, they surprise you again.” Charlotte Crauwels: I’m not completely sure yet.

  • Dr. AurĂ©lien Rizk | Dr. GPCR Ecosystem

    includes studies in mathematics, physics, and computer science at the French Grande École, École Normale Supérieure GPCR AI Summary AI-generated content may be inaccurate or misleading. Always check for accuracy. Summary Professional Backgrounds and Projects Discussed Yamina Berchiche and Aurelien Rizk had a conversation However, the transcript is somewhat unclear and disjointed, making it difficult to summarize the specific Aurelien Rizk confirmed his attendance at the upcoming GPCR-Targeted Drug Discovery Summit in Boston.

  • This is a Title 02 | Dr. GPCR Ecosystem

    Be sure to click Sync after making changes in a collection, so visitors can see your newest content on

  • Dr. Yamina Berchiche | Dr. GPCR Ecosystem

    Ecosystem, with the goal is to bring together GPCR scientists, biotech, and pharma leaders as well as suppliers

  • Foord: Serendipity, RAMPs, And Industrial GPCR Pharmacology | Dr. GPCR Ecosystem

    blotting, cross-hybridization, and later genetic analyses ultimately showed that some hypothesized subtypes Later hepatotoxicity concerns and the success of antibody therapeutics further shifted strategy. For younger scientists, his advice centers on doing work you genuinely enjoy, finding supervisors who antibodies. 20:00 — Angiotensin receptor work, using Southern blots to hunt for a non-existent AT1 subtype via yeast two-hybrid, and closing the chapter on proposed additional GABA B subtypes. 39:00 — Large-scale

  • Dr. Prasenjit Saha | Dr. GPCR Ecosystem

    attention as they have the potential to fine-tune cellular responses with greater selectivity among the subtypes

  • Dr. John Janetzko | Dr. GPCR Ecosystem

    Daniel Kahne and Suzanne Walker studying the structure and function of the essential human enzyme, O-GlcNAc GPCR AI Summary AI-generated content may be inaccurate or misleading. Always check for accuracy. He then moved to Dan's lab where he met Suzanne and her project. Ultimately, John did join the lab after his girlfriend successfully matched at Stanford. Yamina suggested having round tables to discuss these topics.

  • Gunnar Schulte: Frizzled Receptors and the GPCR Identity Question | Dr. GPCR Ecosystem

    Schulte: Frizzled Receptors and the GPCR Identity Question Frizzled receptors are a family of 10 cell surface signaling appears G-protein-independent, and almost no small molecule pharmacology exists for this subfamily evidence on the other side — demonstrating G-protein coupling specificity across individual frizzled subtypes Fewer than one in 19 Wnt ligands is currently available in a biologically active, tagged form suitable Combined with porcupine inhibitors to suppress endogenous Wnt secretion, this system has become what

  • Receptor Signaling Bias: A Valuable and Accessible Property of New Drug Candidates | Dr. GPCR Ecosystem

    cell-based assays spanning basic research through therapeutic discovery, optimization, and regulatory submission

  • Custom Molecules, Fluorescent Probes: When Chemists Think Like Biologists with Dr. Maria Majellaro from Celtarys | Dr. GPCR Ecosystem

    I wasn’t sure at first, but I realized I could do this too.” — Maria Majellaro Her decisions, often made That changed with support from Galicia’s robust biotech network, and the company quickly defined its The Complexity Behind Every “Successful” Probe Maria is candid about the technical challenges behind Their work directly supports the tool-building mission that aligns with the Dr. GPCR ecosystem. To date, she has successfully led seven funded projects.

  • Dr. Demet Araç | Dr. GPCR Ecosystem

    GPCR AI Summary AI-generated content may be inaccurate or misleading. Always check for accuracy. Summary Personal Backgrounds and GPCR Interest Yamina and Demet had a discussion about their personal Demet, who had studied various subjects including chemistry, physics, biology, and math, shared his interest project since 2013, screening about 20 adhesion GPCRs, with the Latrophilin 3 construct proving most successful

  • Dylan Eiger | Dr. GPCR Ecosystem

    Sudarshan Rajagopal, a former postdoctoral fellow of Dr. Robert J. Lefkowitz . GPCRs, specifically, the role of differential receptor phosphorylation (phosphorylation barcodes) and subcellular After finishing his MD/Ph.D., Dylan plans to complete his residency training in Internal Medicine and subsequently

  • Bryan Roth: Inside the DARPA Bet on a Non-Psychedelic Psychedelic | Dr. GPCR Ecosystem

    Roth is direct about this: with sufficient medicinal chemistry resources and modern assays, you can make The internet seller who supplied the compound disagreed, took naloxone, smoked salvia to disprove it, Louis University in 1983, he subsequently trained in pharmacology (NIH), molecular biology, and psychiatry

  • Dr. Nicholas Holliday | Dr. GPCR Ecosystem

    undergraduate degree at the University of Cambridge, Nick carried out his Ph.D. at King’s College London, supported It was these studies and subsequent postdoctoral work that led to Nick's interest in peptide messengers

  • Mark Schmeizl | Dr. GPCR Ecosystem

    He has successfully built numerous global life science, leadership teams, & works closely with both clients

  • Michel Bouvier: BRET, Biased Agonism, and the Tools That Changed GPCR Pharmacology | Dr. GPCR Ecosystem

    Rather than wait, Bouvier's team submitted elsewhere and started building. In the lab meeting that followed, someone suggested that a lipophilic antagonist might penetrate to the separate the two - invoking the Axelrod anecdote not to diminish intelligence but to make the case that sustained He has supervised the research work of 75 graduate students and 40 post-doctoral fellows.

  • Ross Cheloha: Nanobody-GPCR Conjugates and the Engineering of Receptor Selectivity | Dr. GPCR Ecosystem

    And can selectivity for one receptor subtype be engineered without redesigning the ligand from scratch 10,000-fold, and how the selectivity of the nanobody - not the ligand - is what engineers receptor subtype have been using this distinction all along: two natural ligands for the same receptor already show subtly The working model is that the nanobody anchors the conjugate at the receptor surface, positioning the Attaching a short PTH fragment to a PTHR1-selective nanobody produces a ligand selective for that subtype

  • Brian Bender: Computational Probes for Orphan GPCR | Dr. GPCR Ecosystem

    Back to podcast list Strategic Partner(s) Brian Bender: Computational Probes for Orphan GPCR The GPCR superfamily Finding an endogenous agonist - when one is even known - is rarely sufficient: a large peptide or lipidated for pan-GPCR chemical probe discovery The orphan receptor problem - why endogenous agonists are not sufficient it became a forced pivot into computation at precisely the moment his modeling skills were becoming sufficient - produced an unexpected result: structural and sequence patterns connecting receptors across GPCR subfamilies

  • Tore Bengtsson: Rethinking β₂-Adrenergic Signaling in Metabolic Disease | Dr. GPCR Ecosystem

    The intense physiological response—an adrenaline surge and rapid adaptation to cold—sparked his lifelong One summer he asked me: “What happens if you fall through the ice?” I said I didn't know. Suddenly he pushed me into the icy water. I remember the intense adrenaline surge. My body reacted instantly. I wasn't even cold at first. Bengtsson: And another lesson I learned from my wife: success often depends not just on knowledge but

  • This is a Title 03 | Dr. GPCR Ecosystem

    Be sure to click Sync after making changes in a collection, so visitors can see your newest content on

  • Why Mosquitoes Hunt You: GPCR Control of Blood Feeding and Mating | Dr. GPCR Ecosystem

    Laura Duvall's lab has traced this suppression to a specific neuropeptide Y family receptor, one she to study neuropeptide Y family receptors in Aedes aegypti, with a particular focus on host seeking suppression Duvall's lab used CRISPR to mutate the receptor she had identified as important for host seeking suppression favorite includes a receptor in the female mosquito that detects a male derived signal after mating and suppresses research facility from scratch, and what day to day lab life looks like - The receptor behind mating suppression

  • Lin and Ball: GPCR Antibody Characterization and the Recombinant Shift | Dr. GPCR Ecosystem

    Chia-Yi Lin is the head of international sales, marketing, technical support, and logistics at GeneTex reproducibility Researcher-company collaboration as an active ingredient in antibody quality - not a support single rabbit is immunized, the choice of immunogen has already determined whether a GPCR antibody can succeed Ball recounts his company's president going pale when the subject came up: every commercial antibody

  • Martin Audet | Dr. GPCR Ecosystem

    Strong education with a Doctor of Philosophy (Ph.D.) in biochemistry under the supervision of Michel

  • Dr. Raul Gainetdinov | Dr. GPCR Ecosystem

    Since 2013, he has been elected Chair of the subcommittee for the Dopamine receptors of the International

  • Xylazine, Fentanyl, and the Fight for Breath with Catherine Demery | Dr. GPCR Ecosystem

    And while users aren’t asking for xylazine, dealers are lacing it into the supply—driving overdose deaths

  • Team Access to Terry’s Pharmacology Corner | 25% Group Discount | Dr. GPCR Ecosystem

    live AMA discussions with Terry Kenakin • Ongoing Terry’s Corner lessons and analysis • Ability to suggest GPCR Ecosystem account . 2 — Submit Your Team Details Provide names, emails, and organization information

  • Graciela Pineyro: Resilience, Lab Life, and the Zoom Effect | Dr. GPCR Ecosystem

    planning in self-contained blocks, flatter meeting dynamics, planned reflection time — may deserve to survive Pineyro notes she isn't sure why — something about speaking from home, something about reduced interpersonal Some pandemic-era practices deserve to survive. Not because the pandemic was good for science, but because normal lab life had quietly suppressed some Episode Timeline Timestamps were generated using AI for readability. 00:00 Introduction and 2020 Summit

bottom of page